Report of a Korean Patient with Cystic Fibrosis, Carrying Q98R and Q220X Mutations in the CFTR Gene.
10.3346/jkms.2006.21.3.563
- Author:
Won Jung KOH
1
;
Chang Seok KI
;
Jong Won KIM
;
Jeong Ho KIM
;
Seong Yong LIM
Author Information
1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Cystic Fibrosis;
Cystic Fibrosis Transmembrane Conductance Regulator, CFTR;
Mutation
- MeSH:
Radiography, Thoracic;
Pedigree;
*Mutation;
Male;
Korea;
Humans;
Heterozygote;
*Genetic Predisposition to Disease;
Female;
DNA Mutational Analysis;
Cystic Fibrosis Transmembrane Conductance Regulator/*genetics;
Cystic Fibrosis/*genetics;
Adolescent
- From:Journal of Korean Medical Science
2006;21(3):563-566
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although cystic fibrosis (CF) is one of the most frequently seen autosomal-recessive disorders in Caucasians, it is extremely rare in the Korean population. Recently, a 15-yr-old Korean boy was admitted to our hospital complaining of coughing, sputum, and exertional dyspnea. Chest radiographs and computed tomographic chest and paranasal sinus scans revealed diffuse bronchiectasis and pansinusitis. Pulmonary function tests revealed severe obstructive impairment. The average sweat chloride concentrations on both of the patients' forearms were 63.0 mM/L (reference limit: < 40 mM/L). Upon mutation analysis, two different mutations (Q98R and Q220X) were identified in the cystic fibrosis transmembrane conductance regulator gene, both of which had been previously detected in CF patients, one from France and the other from England. As CF is quite rare in Korea, the diagnosis of CF in this patient might be delayed. Therefore, we recommend that a diagnosis of CF should be suspected in patients exhibiting unexplained chronic respiratory symptoms.
